AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Optimisation Strategy for Emergency Tracheal Intubation

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Bordeaux
💬

In plain words

What the trial is, and whether it could suit you

This study has to objective to assess, in adults' patients needing tracheal intubation because of vital distress, the effect of a combined strategy to reduce intubation-related morbidity. This strategy will associate systematic use of rocuronium as paralyzing agent to facilitate tracheal intubation, bag face-mask ventilation before intubation and Gum Elastic Bougie (GEB) use.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patient adult (≥ 18 years) presenting with vital distress requiring emergency tracheal intubation as assessed by the emergency physician in the out-of-hospital setting. * Patient with all conditions (trauma, dyspnea, coma, overdoses, and shock) except those in cardiac arrest will be included. Exclusion Criteria: * Patient presenting of a contraindication to succinylcholine, and/or rocuronium, and/or sugammadex (rocunorium antagonist). * Patient who have contraindication to bag face mask ventilation before intubation (ongoing emesis, hematemesis, or hemoptysis). * Patient that are not members of a medical aid scheme (beneficiary or main member). * Patient under specific protection measures: pregnant, parturient or nursing women; legal protection or deprived of liberty: patient under judicial protection, patient under guardianship/curatorship.
💊

What it tests

  • Data patient
  • Physical examination
  • Rapid sequence intubation (RSI) : Rocuronium /Bag-mask ventilation /GEB
  • Rapid sequence intubation (RSI) : Recommendations for emergency intubation
📍

Where

22 sites
CHU d'Angers
Angers, France
CH Carnelle Portes de l'Oise
Beaumont-sur-Oise, France
AP-HP - Hôpital Avicenne
Bobigny, France
CHU de Bordeaux - Hôpital Pellegrin
Bordeaux, France
CH de Pontoise René Dubos
Cergy-Pontoise, France
AP-HP - Hôpital Henri Mondor
Créteil, France
CHU de Dijon
Dijon, France
GH Eaubonne Montmorency Hôpital Simone VEIL
Eaubonne, France

…and 14 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy